The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Overtreatment of Young Adults With Colon Cancer: More Intense Treatments With Unmatched Survival Gains
Abstract
IMPORTANCE: Colon cancer is increasing among adults younger than 50 years. However, the prognosis of young-onset colon cancer remains poorly defined given significant age-related demographic, disease, and treatment differences. OBJECTIVE: To define stage-specific treatments and prognosis of colon cancer diagnosed in young adults (ages 18-49 years) vs older adults (ages 65-75 years) outside of the clinical trial setting while accounting for real-world age-related variations in patient, tumor, and treatment factors. DESIGN, SETTING, AND PARTICIPANTS: A nationwide cohort study was conducted among US hospitals accredited by the American College of Surgeons Commission on Cancer. Participants were 13 102 patients diagnosed as having young-onset colon adenocarcinoma aged 18 to 49 years and 37 007 patients diagnosed as having later-onset colon adenocarcinoma aged 65 to 75 years treated between January 1, 2003, and December 31, 2005, and reported to the National Cancer Data Base. EXPOSURES: Patients who underwent surgical resection and postoperative systemic chemotherapy of curative intent. MAIN OUTCOMES AND MEASURES: The primary end point was stage-specific relative survival, an objective measure of survival among patients with cancer, adjusting for baseline mortality rates and independent of the data on cause of death. The secondary end point was stage-specific likelihood of receiving postoperative systemic chemotherapy. RESULTS: Most young-onset colon cancer was initially seen at advanced stages (61.8% had stage III or IV). After adjusting for patient-related and tumor-related factors, young patients were more likely to receive systemic chemotherapy, particularly multiagent regimens, at all stages relative to those with later-onset disease. These odds ratios were 2.88 (95% CI, 2.21-3.77) for stage I, 3.93 (95% CI, 3.58-4.31) for stage II, 2.42 (95% CI, 2.18-2.68) for stage III, and 2.74 (95% CI, 2.44-3.07) for stage IV. The significantly more intense treatments received by younger patients were unmatched by any survival gain, which was nil for stage II (relative risk, 0.90; 95% CI, 0.69-1.17) and marginal for stage III (relative risk, 0.89; 95% CI, 0.81-0.97) and stage IV (relative risk, 0.84; 95% CI, 0.79-0.90). CONCLUSIONS AND RELEVANCE: Young adults with colon cancer received significantly more postoperative systemic chemotherapy at all stages, but they experienced only minimal gain in adjusted survival compared with their older counterparts who received less treatment. This mismatch suggests that attention should be given to long-term cancer survivorship in young adults with colon cancer because they likely face survivorship needs that are distinct from those of their older counterparts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
André, T., Boni, C., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Bonetti, A., Clingan, P., Bridgewater, J., Rivera, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6771 · Cited by 2,277
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623
The relative survival rate: a statistical methodology.
Ederer, F., Axtell, L. M., & CUTLER, S. J. (1961) · PubMed · Cited by 1,169
Microsatellite Instability in Colorectal Cancer-the Stable Evidence
Vilar, E., & Gruber, S. B. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.237 · Cited by 1,063
Self-citationRegression models for relative survival
Dickman, P. W., Sloggett, A., Hills, M., & Hakulinen, T. (2004) · Statistics in Medicine · doi:10.1002/sim.1597 · Cited by 792
The distinctive biology of cancer in adolescents and young adults
on behalf of the Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology, Bleyer, A., Barr, R., Hayes-Lattin, B., Thomas, D., Ellis, C., & Anderson, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2349 · Cited by 660
Increase in Incidence of Colorectal Cancer Among Young Men and Women in the United States
Siegel, R. L., Jemal, A., & Ward, E. M. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0186 · Cited by 479
The Increasing Incidence of Young-Onset Colorectal Cancer: A Call to Action
Ahnen, D. J., Wade, S. W., Jones, W. F., Sifri, R., Mendoza Silveiras, J., Greenamyer, J., Guiffre, S., Axilbund, J., Spiegel, A., & You, Y. N. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.09.006 · Cited by 448
Self-citationColorectal cancer in the young
O'Connell, J. B., Maggard, M. A., Livingston, E. H., & Yo, C. K. (2004) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2003.12.020 · Cited by 349
Young-Onset Colorectal Cancer: Is It Time to Pay Attention?
You, Y. N. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.602 · Cited by 273
Self-citationDo Young Colon Cancer Patients Have Worse Outcomes?
O’Connell, J. B., Maggard, M. A., Liu, J. H., Etzioni, D. A., Livingston, E. H., & Ko, C. Y. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7306-7 · Cited by 247
Land, S. R., Kopec, J. A., Cecchini, R. S., Ganz, P. A., Wieand, H. S., Colangelo, L. H., Murphy, K., Kuebler, J. P., Seay, T. E., Needles, B. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6652 · Cited by 239
Adherence to Stage-Specific Treatment Guidelines for Patients With Colon Cancer
Chagpar, R., Xing, Y., Chiang, Y., Feig, B. W., Chang, G. J., You, Y. N., & Cormier, J. N. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.6937 · Cited by 149
Self-citationBerg, M., Danielsen, S. A., Ahlquist, T. C., Merok, M. A., Ågesen, T. H., Vatn, M. H., Mala, T., Sjo, O. H., Bakka, A. O., Moberg, I. O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013978 · Cited by 137
Young Age Influences Treatment but not Outcome of Colon Cancer
Quah, H. M., Joseph, R., Schrag, D., Shia, J., Guillem, J. G., Paty, P. B., Temple, L. K. F., Wong, W. D., & Weiser, M. R. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9465-x · Cited by 131
Are We Undertreating Rectal Cancer in the Elderly?
Chang, G. J., Skibber, J. M., Feig, B. W., & Rodrı́guez-Bigas, M. A. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318070838f · Cited by 122
Self-citationYou, Y. N., Dozois, E. J., Boardman, L. A., Aakre, J. A., Huebner, M., & Larson, D. W. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1674-7 · Cited by 109
Self-citationBalancing the efficacy and toxicity of chemotherapy in colorectal cancer
Braun, M. S., & Seymour, M. T. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010388342 · Cited by 100
Kidwell, K., Yothers, G., Ganz, P. A., Land, S. R., Ko, C. Y., Cecchini, R. S., Kopec, J. A., & Wolmark, N. (2012) · Cancer · doi:10.1002/cncr.27593 · Cited by 95
Hu, C., Xing, Y., Cormier, J. N., & Chang, G. J. (2013) · Cancer · doi:10.1002/cncr.27968 · Cited by 86
Self-citationBlanke, C. D., Bot, B. M., Thomas, D. M., Bleyer, A., Köhne, C.-H., Seymour, M., de Gramont, A., Goldberg, R. M., & Sargent, D. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5281 · Cited by 86
Limburg, P. J., Harmsen, W. S., Chen, H., Gallinger, S., Haile, R. W., Baron, J. A., Casey, G., Woods, M. O., Thibodeau, S. N., & Lindor, N. M. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.10.021 · Cited by 71
Abrams, T. A., Brightly, R., Mao, J., Kirkner, G. J., Meyerhardt, J. A., Schrag, D., & Fuchs, C. S. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.0058 · Cited by 65
Hubbard, J. M., Thomas, D. M., Yothers, G., Green, E., Blanke, C. D., O’Connell, M. J., Labianca, R., Shi, Q., Bleyer, A., de Gramont, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.1975 · Cited by 41
岩崎, 順., & 大津, 敦. (2004) · Mebio oncology · Cited by 23
Cited by
Colorectal cancer statistics, 2023
Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21772 · Cited by 3,733
Patel, S. G., Karlitz, J. J., Yen, T., Lieu, C. H., & Boland, C. R. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00426-x · Cited by 812
Rising incidence of early-onset colorectal cancer — a call to action
Akimoto, N., Ugai, T., Zhong, R., Hamada, T., Fujiyoshi, K., Giannakis, M., Wu, K., Cao, Y., Ng, K., & Ogino, S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00445-1 · Cited by 728
Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults
Stoffel, E. M., & Murphy, C. C. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.07.055 · Cited by 637
Early‐onset colorectal cancer in young individuals
Mauri, G., Sartore‐Bianchi, A., Russo, A., Marsoni, S., Bardelli, A., & Siena, S. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12417 · Cited by 634
Metadata
- Authors
- Kneuertz, P. J., Chang, G. J., Hu, C.-Y., Rodriguez-Bigas, M. A., Eng, C., Vilar, E., Skibber, J. M., Feig, B. W., Cormier, J. N., & You, Y. N.
- Venue
- JAMA Surgery
- Publisher
- American Medical Association (AMA)
- Published
- 2015-05-01
- Volume
- 150
- Issue
- 5
- Pages
- 402
- ISSN
- 2168-6254 (ISSN-L)
- OpenAlex
- W2014904574
- Cited by
- 284
- References
- 31
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.